Companion Animal Welfare

Feline Hyperthyroidism — Long-term Welfare Management

Hyperthyroidism is the most common endocrine disease of older cats, causing chronic suffering through weight loss, cardiac disease, and hypertension if untreated, but highly responsive to effective management.

Key Facts

Welfare Considerations

Hyperthyroidism creates prolonged suffering that is frequently misattributed to normal aging until the diagnosis is made. Affected cats lose weight despite ravenous appetites, experience gastrointestinal upset, and in many cases develop hypertension that silently damages kidneys, heart, and eyes. The hyperactivity and vocalisation associated with hyperthyroidism is distressing for owners but also reflects physiological dysregulation that is uncomfortable for the cat — chronic excess sympathetic stimulation causes anxiety-like states and disturbed sleep. Effective treatment transforms quality of life: well-managed cats regain weight, reduce gastrointestinal signs, and show behavioural normalisation within weeks. The welfare trade-off in treatment choice involves duration and stability — daily medication requires long-term commitment and periodic monitoring; radioiodine requires a 2-4 week quarantine period at a specialist facility but then provides cure. The masked renal insufficiency phenomenon — where treatment reveals underlying kidney disease previously hidden by hyperthyroid-driven hyperfiltration — requires careful management during treatment initiation.

What You Can Do